Jove
Visualize
Contact Us

Related Experiment Videos

BTKbase, mutation database for X-linked agammaglobulinemia (XLA)

M Vihinen1, O Brandau, L J Brandén

  • 1Department of Biosciences, Division of Biochemistry, PO Box 56, FIN-00014 University of Helsinki, Finland. mauno.vihinen@helsinki.fi

Nucleic Acids Research
|February 21, 1998
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibody Level against Hepatitis B Virus in Term and Preterm Infants Following Three Doses of Pentavalent Vaccine as per EPI Schedule.

Mymensingh medical journal : MMJ·2025
Same author

Status of Serum Iron in Patients with Chronic Obstructive Pulmonary Disease.

Mymensingh medical journal : MMJ·2024
Same author

Association of Vitamin D Deficiency with Late Onset Neonatal Sepsis in Term and Late Preterm Neonates.

Mymensingh medical journal : MMJ·2024
Same author

Evaluation of Socio-Demographic Profile, Biochemical Parameters and Etiology of End Stage Renal Disease Patients in a Tertiary Care Hospital of Bangladesh.

Mymensingh medical journal : MMJ·2024
Same author

Status of Serum Calcium in Patients with Chronic Obstructive Pulmonary Disease.

Mymensingh medical journal : MMJ·2024
Same author

Status of Serum Magnesium and Uric Acid in Patients with Chronic Obstructive Pulmonary Disease.

Mymensingh medical journal : MMJ·2023
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

X-linked agammaglobulinemia (XLA) is an immunodeficiency linked to Bruton's agammaglobulinemia tyrosine kinase (BTK) gene mutations. BTKbase now catalogs 463 mutations from 406 families, detailing phenotypes and structural impacts.

Area of Science:

  • Immunology
  • Genetics
  • Biochemistry

Background:

  • X-linked agammaglobulinemia (XLA) is a primary immunodeficiency disorder.
  • It results from mutations in the Bruton's agammaglobulinemia tyrosine kinase (BTK) gene.
  • Understanding BTK mutations is crucial for diagnosing and potentially treating XLA.

Purpose of the Study:

  • To update and enhance the BTKbase database with new mutation entries and features.
  • To provide a comprehensive resource for researchers studying BTK mutations and XLA.
  • To catalog disease phenotypes associated with specific BTK mutations.

Main Methods:

  • Compilation and curation of mutation data from scientific literature and clinical reports.
  • Inclusion of genetic variants, polymorphisms, and associated patient phenotypes.

Related Experiment Videos

  • Analysis of mutation distribution across BTK domains and identification of common mutation types (e.g., missense).
  • Main Results:

    • The updated BTKbase contains 463 mutation entries from 406 families, representing 303 unique molecular events.
    • Mutations affect all five domains of BTK, with missense mutations being the most common.
    • The database includes information on patient phenotypes and putative structural implications of missense mutations.

    Conclusions:

    • BTKbase serves as a valuable, updated resource for XLA research.
    • The comprehensive data aids in understanding the genotype-phenotype correlations in XLA.
    • The database facilitates further investigation into the structural and functional consequences of BTK mutations.